PTS Detect Cotinine, Ref. No. 3061, UPC 381933061017 in vitro diagnostic - Product Usage: The PTS...
FDA Device Recall #Z-1438-2020 — Class II — January 21, 2020
Recall Summary
| Recall Number | Z-1438-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 21, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Polymer Technology Systems, Inc. |
| Location | Indianapolis, IN |
| Product Type | Devices |
| Quantity | 6790 |
Product Description
PTS Detect Cotinine, Ref. No. 3061, UPC 381933061017 in vitro diagnostic - Product Usage: The PTS Detect cotinine system provides quantitative measurement of the nicotine metabolite cotinine (25 200 ng/mL) in capillary (fingerstick) or venous whole blood. The test is for professional use to determine if an individual has been exposed to nicotine.
Reason for Recall
The firm is removing the product from the market after discussions with the FDA due to lack of 510(k) clearance.
Distribution Pattern
Domestic distribution nationwide. Foreign distribution to Belgium, South Africa, South Korea, and Poland.
Lot / Code Information
1811715 1831313 1831324 1831325
Other Recalls from Polymer Technology Systems, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0832-2020 | Class II | PTS Diagnostics CardioChek Plus Professional An... | Dec 2, 2019 |
| Z-0835-2020 | Class II | Henry Schein CardioChek Plus Professional Analy... | Dec 2, 2019 |
| Z-0833-2020 | Class II | PTS Diagnostics CardioChek Plus Professional An... | Dec 2, 2019 |
| Z-0834-2020 | Class II | Henry Schein CardioChek Starter Kit, Reference ... | Dec 2, 2019 |
| Z-2157-2019 | Class III | PTS Panels Lipid Panel test strip: IVD Lipid P... | Jun 7, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.